Hypoalbuminemia is a risk factor for invasive fungal infections and poor outcomes in infected kidney transplant recipients.
albumin
fungal
immunosuppressed
infections
transplant
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
13
05
2023
received:
24
01
2023
accepted:
08
06
2023
medline:
23
10
2023
pubmed:
17
6
2023
entrez:
17
6
2023
Statut:
ppublish
Résumé
Invasive fungal infections (IFI), are estimated to occur in 2%-14% of kidney transplant recipients (KTRs) in the current era of immune suppression and are associated with high mortality rates. We hypothesized that hypoalbuminemia in KTRs is a risk factor for IFI and would be associated with poor outcomes. In this study, using data from a prospective cohort registry, we describe the frequency of IFI due to Blastomycosis, Coccidioidomycosis, Histoplasmosis, Aspergillosis, and Cryptococcus in KTRs with serum albumin levels measured 3-6 months before diagnosis. Controls were selected based on incidence density sampling. KTRs were divided into three groups based on the pre-IFI serum albumin level: normal (≥4 g/dL), mild (3-4 g/dL), or severe (<3 g/dL) hypoalbuminemia. Outcomes of interest were uncensored graft failure after IFI and overall mortality. A total of 113 KTRs with IFI were compared with 348 controls. The incidence rate of IFI among individuals with normal, mild, and severe hypoalbuminemia was 3.6, 8.7, and 29.3 per 100 person-years, respectively. After adjustment for multiple variables, the trend for risk of uncensored graft failure following IFI was greater in KTRS with mild (HR = 2.1; 95% CI, .75-6.1) and severe (HR = 4.47; 95% CI, 1.56-12.8) hypoalbuminemia (P-trend < .001) compared to those with normal serum albumin. Similarly, mortality was higher in severe hypoalbuminemia (HR = 1.9; 95% CI, .67-5.6) compared to normal serum albumin (P-trend < .001). Hypoalbuminemia precedes the diagnosis of IFI in KTRs, and is associated with poor outcomes following IFI. Hypoalbuminemia may be a useful predictor of IFI in KTRs and could be incorporated into screening algorithms.
Substances chimiques
Serum Albumin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15052Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Snydman DR. Epidemiology of infections after solid-organ transplantation. Clin Infect Dis. 2001;33(Suppl 1):S5-8.
Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010;12(3):220-229.
Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011;17(10):1855-1864.
Karuthu S, Blumberg EA. common infections in kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(12):2058-2070.
Parajuli S, Wick A, Pandeya S, et al. The feared five fungal infections in kidney transplant recipients: a single-center 20-year experience. Clin Transplant. 2018;32(7):e13289.
Kotton CN, Fishman JA. Viral infection in the renal transplant recipient. J Am Soc Nephrol. 2005;16(6):1758-1774.
Jha V. Post-transplant infections: an ounce of prevention. Indian J Nephrol. 2010;20(4):171-178.
Cukuranovic J, Ugrenovic S, Jovanovic I, Visnjic M, Stefanovic V. Viral1 infection in renal transplant recipients. Sci World J. 2012:18.
Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319-334.
Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3(5):1487-1493.
Guedes-Marques M, Romaozinho C, Santos L, Macario F, Alves R, Mota A. Kidney transplantation: which variables should be improved? Transplant Proc. 2015;47(4):914-919.
Minatoguchi S, Nomura A, Imaizumi T, et al. Low serum albumin as a risk factor for infection-related in-hospital death among hemodialysis patients hospitalized on suspicion of infectious disease: a Japanese multicenter retrospective cohort study. Ren Replace Ther. 2018;4(1):30.
Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clinical Clin J Am Soc Nephrol. 2008;3(3):759-767.
Goldwasser P, Mittman N, Antignani A, et al. Predictors of mortality in hemodialysis-patients. Clin J Am Soc Nephrol. 1993;3(9):1613-1622.
Becker BN, Becker YT, Heisey DM, et al. The impact of hypoalbuminemia in kidney-pancreas transplant recipients. Transplantation. 1999;68(1):72-75.
Kato TS, Cheema FH, Yang J, et al. Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation. Circ Heart Fail. 2013;6(4):785-791.
Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ, Kasiske BL. Serum albumin and mortality after renal transplantation. Am J Kidney Dis. 1996;27(1):117-123.
Dahlberg R, Muth B, Samaniego M, Hofmann RM, Pirsch J, Djamali A. One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients. J Ren Nutr. 2010;20(6):392-397.
Molnar MZ, Kovesdy CP, Bunnapradist S, et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant. 2011;11(5):1006-1015.
Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012;7(Suppl 3):S193-199.
Wiedermann CJ. Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci. 2021;22(9). doi:10.3390/ijms22094496
Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and Clinical Significance. JPEN JParenterEnterNutr. 2019;43(2):181-193.
Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204-7218.
Ballmer PE. Causes and mechanisms of hypoalbuminaemia. Clin Nutrition (Edinburgh, Scotland). 2001;20(3):271-273.
Musk M, Chambers D, Chin W, Murray R, Gabbay E. Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant. 2006;25(10):1268-1272.
Husain S, Muñoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 2005;40(1):89-99.
Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7-14.
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
Yousif EAI, Muth B, Manchala V, et al. In kidney recipients from the same deceased donor, discordance in delayed graft function is associated with the worst outcomes. Clin Transplant. 2022;36(9):e14779.
Srivastava A, Bodnar J, Osman F, et al. Serum albumin level before kidney transplant predicts post-transplant BK and possibly cytomegalovirus infection. Kidney Int Rep. 2020;5(12):2228-2237.
Parajuli S, Joachim E, Alagusundaramoorthy S, et al. Subclinical antibody-mediated rejection after kidney transplantation: treatment outcomes. Transplantation. 2019;103(8):1722-1729.
Cunningham KC, Hager DR, Fischer J, et al. Single-dose basiliximab induction in low-risk renal transplant recipients. Pharmacotherapy. 2016;36(7):823-829.
Low CY, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Med Rep. 2011;3:14.
Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol. 2007;45(4):305-320.
De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
Shoham S, Marr KA. Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 2012;7(5):639-655.
Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet (London, England). 2002;359(9302):248-252.